Search

everythinglearnresearchcommunity

for

Search:↓

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Hair transplantation can effectively treat stable eyebrow hair loss in alopecia areata patients.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Immune activities and specific genes are important in male pattern baldness.

PRP is effective in treating male pattern baldness.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Alcohol-free minoxidil 5% is effective and safe for treating male pattern hair loss.

Both genetics and lifestyle factors contribute to male pattern baldness.

Certain gut bacteria may increase or decrease the risk of male pattern baldness.

Fibrosis in the bulge area of hair follicles can cause hair thinning in male pattern baldness, and drugs that inhibit fibrosis might help reverse this.

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

A baby girl has a hair disorder called monilethrix, causing fragile hair that may improve over time.

Some breast cancer chemotherapy can cause permanent hair loss.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Hair loss due to syphilis can be identified using trichoscopy and is treatable with antibiotics.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Women with hair loss have more androgen receptors in certain hair follicles.

Red and infrared light therapy improves hair growth in balding patients.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.